Arunis Abode Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 20, 2025, 9:28 pm

Competitors of Arunis Abode Ltd

All Competitor Stocks of Arunis Abode Ltd

Quarterly Result

Last Updated: August 19, 2025, 11:25 pm

Below is a detailed analysis of the quarterly data for Arunis Abode Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 13.60 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 13.60 Cr., marking an increase of 13.60 Cr..
• For Expenses, as of Jun 2025, the value is 7.88 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.15 Cr. (Mar 2025) to 7.88 Cr., marking an increase of 7.73 Cr..
• For Operating Profit, as of Jun 2025, the value is 5.72 Cr.. The value appears strong and on an upward trend. It has increased from -0.15 Cr. (Mar 2025) to 5.72 Cr., marking an increase of 5.87 Cr..
• For OPM %, as of Jun 2025, the value is 42.06%. The value appears strong and on an upward trend. It has increased from 0.00% (Mar 2025) to 42.06%, marking an increase of 42.06%.
• For Other Income, as of Jun 2025, the value is 0.48 Cr.. The value appears strong and on an upward trend. It has increased from 0.16 Cr. (Mar 2025) to 0.48 Cr., marking an increase of 0.32 Cr..
• For Interest, as of Jun 2025, the value is 0.02 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.01 Cr. (Mar 2025) to 0.02 Cr., marking an increase of 0.01 Cr..
• For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.01 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.01 Cr..
• For Profit before tax, as of Jun 2025, the value is 6.18 Cr.. The value appears strong and on an upward trend. It has increased from -0.01 Cr. (Mar 2025) to 6.18 Cr., marking an increase of 6.19 Cr..
• For Tax %, as of Jun 2025, the value is 15.05%. The value appears to be increasing, which may not be favorable. It has increased from -2,000.00% (Mar 2025) to 15.05%, marking an increase of 2,015.05%.
• For Net Profit, as of Jun 2025, the value is 5.25 Cr.. The value appears strong and on an upward trend. It has increased from 0.19 Cr. (Mar 2025) to 5.25 Cr., marking an increase of 5.06 Cr..
• For EPS in Rs, as of Jun 2025, the value is 17.50. The value appears strong and on an upward trend. It has increased from 0.63 (Mar 2025) to 17.50, marking an increase of 16.87.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 3:55 am

Growth

Last Updated: September 5, 2025, 2:25 pm

Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Arunis Abode Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -0.51. This value is below the healthy minimum of 5. It has decreased from 1.31 (Mar 24) to -0.51, marking a decrease of 1.82.
• For Diluted EPS (Rs.), as of Mar 25, the value is -0.51. This value is below the healthy minimum of 5. It has decreased from 1.31 (Mar 24) to -0.51, marking a decrease of 1.82.
• For Cash EPS (Rs.), as of Mar 25, the value is -0.07. This value is below the healthy minimum of 3. It has decreased from 2.10 (Mar 24) to -0.07, marking a decrease of 2.17.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 21.07. It has decreased from 21.58 (Mar 24) to 21.07, marking a decrease of 0.51.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 21.07. It has decreased from 21.58 (Mar 24) to 21.07, marking a decrease of 0.51.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.00. It has decreased from 4.06 (Mar 24) to 0.00, marking a decrease of 4.06.
• For PBDIT / Share (Rs.), as of Mar 25, the value is -0.92. This value is below the healthy minimum of 2. It has decreased from 3.66 (Mar 24) to -0.92, marking a decrease of 4.58.
• For PBIT / Share (Rs.), as of Mar 25, the value is -1.37. This value is below the healthy minimum of 0. It has decreased from 3.07 (Mar 24) to -1.37, marking a decrease of 4.44.
• For PBT / Share (Rs.), as of Mar 25, the value is -1.59. This value is below the healthy minimum of 0. It has decreased from 1.99 (Mar 24) to -1.59, marking a decrease of 3.58.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -0.50. This value is below the healthy minimum of 2. It has decreased from 1.52 (Mar 24) to -0.50, marking a decrease of 2.02.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -0.50. This value is below the healthy minimum of 2. It has decreased from 1.31 (Mar 24) to -0.50, marking a decrease of 1.81.
• For PBDIT Margin (%), as of Mar 25, the value is -278,500.00. This value is below the healthy minimum of 10. It has decreased from 89.98 (Mar 24) to -278,500.00, marking a decrease of 278,589.98.
• For PBIT Margin (%), as of Mar 25, the value is -409,800.00. This value is below the healthy minimum of 10. It has decreased from 75.61 (Mar 24) to -409,800.00, marking a decrease of 409,875.61.
• For PBT Margin (%), as of Mar 25, the value is -477,800.00. This value is below the healthy minimum of 10. It has decreased from 49.08 (Mar 24) to -477,800.00, marking a decrease of 477,849.08.
• For Net Profit Margin (%), as of Mar 25, the value is -152,300.00. This value is below the healthy minimum of 5. It has decreased from 37.40 (Mar 24) to -152,300.00, marking a decrease of 152,337.40.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -152,300.00. This value is below the healthy minimum of 8. It has decreased from 32.33 (Mar 24) to -152,300.00, marking a decrease of 152,332.33.
• For Return on Networth / Equity (%), as of Mar 25, the value is -2.40. This value is below the healthy minimum of 15. It has decreased from 6.08 (Mar 24) to -2.40, marking a decrease of 8.48.
• For Return on Capital Employeed (%), as of Mar 25, the value is -6.48. This value is below the healthy minimum of 10. It has decreased from 12.26 (Mar 24) to -6.48, marking a decrease of 18.74.
• For Return On Assets (%), as of Mar 25, the value is -2.12. This value is below the healthy minimum of 5. It has decreased from 4.93 (Mar 24) to -2.12, marking a decrease of 7.05.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.11 (Mar 24) to 0.00, marking a decrease of 0.11.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.12. This value is within the healthy range. It has decreased from 0.13 (Mar 24) to 0.12, marking a decrease of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. It has decreased from 0.13 (Mar 24) to 0.00, marking a decrease of 0.13.
• For Current Ratio (X), as of Mar 25, the value is 8.30. This value exceeds the healthy maximum of 3. It has increased from 4.62 (Mar 24) to 8.30, marking an increase of 3.68.
• For Quick Ratio (X), as of Mar 25, the value is 8.30. This value exceeds the healthy maximum of 2. It has increased from 4.62 (Mar 24) to 8.30, marking an increase of 3.68.
• For Interest Coverage Ratio (X), as of Mar 25, the value is -4.10. This value is below the healthy minimum of 3. It has decreased from 3.39 (Mar 24) to -4.10, marking a decrease of 7.49.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -1.24. This value is below the healthy minimum of 3. It has decreased from 2.41 (Mar 24) to -1.24, marking a decrease of 3.65.
• For Enterprise Value (Cr.), as of Mar 25, the value is 80.58. It has increased from 15.94 (Mar 24) to 80.58, marking an increase of 64.64.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 805,812.00. This value exceeds the healthy maximum of 3. It has increased from 13.07 (Mar 24) to 805,812.00, marking an increase of 805,798.93.
• For EV / EBITDA (X), as of Mar 25, the value is -289.34. This value is below the healthy minimum of 5. It has decreased from 14.53 (Mar 24) to -289.34, marking a decrease of 303.87.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 798,150.00. This value exceeds the healthy maximum of 3. It has increased from 12.40 (Mar 24) to 798,150.00, marking an increase of 798,137.60.
• For Price / BV (X), as of Mar 25, the value is 12.63. This value exceeds the healthy maximum of 3. It has increased from 2.33 (Mar 24) to 12.63, marking an increase of 10.30.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 12.40 (Mar 24) to 0.00, marking a decrease of 12.40.
• For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.00, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness